PLI Scheme Transforms India from Net Importer to Net Exporter of Bulk Drugs in Just Three Years
The PLI scheme has helped India shift from being a net importer of bulk drugs (– INR 1,930 crore in FY 2021-22) to a net exporter (INR 2,280 crore), while significantly reducing the gap between domestic manufacturing capacity and the demand for critical drugs.
Free Trade Agreements (FTAs) | 20/08/2025 | By Dineshwori | 232
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy